Are you a Carer, Occupational Therapist or Physiotherapist? Join our Healsoul.
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo

WHAT TO EXPECT

500
Attendees
250
Healthcare Executives
250
Healthcare Investors

MEET OUR SPEAKERS, PANELISTS, AND JUDGES

John Oyler
Chairman, Co-Founder & CEO
BeiGene

Brad Loncar
CEO
Loncar Investments

David Berry
General Partner
Flagship Pioneering

Stephen Chen
Vice President
CBC Group

Kan Chen
Principal
Qiming Venture Partners

Kevin Chen
Founding Partner
BioTrack Capital

Michelle Chen
VP & Head of Corporate Development
WuXi Biologics

Tony Chen
Chairman, Bayhelix
Partner, Jones Day

Niels Emmerich
Vice President, Global Head
Search & Evaluation, AbbVie

Jennifer Hu
Senior Advisor
Qiming Venture Partners USA

James Huang
Founding Managing Partner
Panacea Venture

Lu Huang
Managing Director
Morningside Ventures

Dongmei Ji
CEO and IC Chairman
GP Healthcare Capital

Yanhong Lin
Founder and Managing Partner
CTIC Capital

Karen Liu
Founding Partner
3E Bioventures Capital

Lin Ni
Partner
TF Capital

Kevin Oliver
Senior Vice President, Head of BD&L
Simcere Pharmaceutical Group

Dianna Qian
Partner
Pivotal Bioventure Partners China

Joan (Huaqiong) Shen
CEO
I-Mab Biopharma

Victor Shi
Managing Partner
Serica Partners

Ching Tan 
Managing Partner,
CD Capital

Jonathan Wang
Chairman and CEO
Inmagene Bio

Steven Wang
Founder & CEO
HighLight Capital

Aimin Wu
Managing Partner and President
SinoPharm Capital

Marietta Wu
Managing Director
Quan Capital

Vincent Xiang
Founding Managing Partner
7G BioVentures

Steve Yang
Co-CEO
Wuxi Apptec

Bing Yuan
Chief Strategy and Business Officer
Cstone Pharmaceuticals

Dewan Zeng
Executive Director
BeiGene

Jianbin Zhang 
Partner
IDG Capital

Tong Zhang
CBO
Genechem

James Zhao
Founding Partner
LYFE Capital

PREVIOUS INVESTMENT FIRM ATTENDEES - 2020 SUMMIT

PROGRAMS

GENERAL ADMISSION

  • 300 active healthcare investors from the US, EU, and Asia
  • Well known investors and speakers

Healthcare Company: $399
Service Provider: $899

REGISTER HERE

ONE-ON-ONE PARTNERING

  • Schedule one-on-one meetings with the most relevant healthcare Investors
  • Easy-to-use scheduling platform

No additional fee. Included in General Admission

REGISTER HERE

PRESENTING PACKAGE

  • Opportunity to present to the most active healthcare Investors at the Summit is limited
  • Format: 15 minutes presenting plus 10 minutes investors review and discussions

Presenting Fee: $2,999 (includes one presenter’s general admission ticket)

APPLY TO PRESENT

EXHIBITION PACKAGE

  • Unlimited possibilities with this digital and interactive exhibition opportunity
  • Fun for potential partners and investors to review companies virtually before scheduling one on one meetings

Exhibition Fee: Starting from $5,000 (includes two general admission tickets)

APPLY TO EXHIBIT

OVERVIEW OF PREVIOUS CTIC HEALTHCARE INVESTMENT SUMMITS

1500
TOTAL ATTENDEES
600
HEALTHCARE COMPANIES ATTENDED IN TOTAL
400
ACTIVE ASIAN HEALTHCARE INVESTORS ATTENDED IN TOTAL
2000
ONE-ON-ONE MEETINGS SCHEDULED
90 %
OF THE ATTENDEES ARE EXECUTIVES AND PARTNER LEVEL

1:1

INVESTOR TO CEO RATIO

Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo
Client Logo

Feedback from CTIC Summit Attendees

“The CTIC Healthcare Summit is the most effective program available in the US to learn about the Chinese healthcare market, establish cross border partnerships, and meet investors ready to finance companies interested in growing in China and the US.”

David Anthony Esposito

“… The conference was fantastic and great for Epic. We couldn’t have made it happen without your help and incredible responsiveness. We are huge fans! Look forward to working with you again in whatever capacity.”

Murali Prahalad

“This was a very productive conference with high-caliber attendees, good discussion topics and impressive investors from the greater China region.”

Eric Kriegstein

“A terrific way to gain insight into the changing Pharma landscape in China, with the added bonus of hosting an excellent forum for one-on-one meetings between investors and companies.“

Attending CEO